Scientific deep-dive
Fat-to-Muscle Ratio: Surgery Versus Drugs
The lean-to-fat ratio improved in both groups at 6, 12 and 24 months. Everyone loses lean tissue when losing weight — the question is the mix, and both interventions improved it.
Arguments about muscle loss almost always use the wrong unit. What matters is not how much lean tissue you lose but the mix — how much lean comes off relative to fat. A cohort study measured exactly that after bariatric surgery and after semaglutide or tirzepatide, and the ratio improved in both groups at every time point.[1]
The numbers
| Time point | Bariatric surgery | GLP-1 receptor agonists |
|---|---|---|
| 6 months | 1.8 | 1.4 |
| 12 months | 2.1 | 1.5 |
| 24 months | 2.0 | 1.5 |
Both groups lost substantial fat mass and moderate fat-free mass, and both improved the ratio between them. Surgery maintained a higher ratio throughout.[1]
Why the comparison between columns is the weak part
This is a single-center cohort study, not a randomized comparison, and people who have bariatric surgery differ enormously from people prescribed a GLP-1 — in starting weight, in how long they have been trying, in what else has failed, and in the post-operative nutrition and follow-up programs that surgery carries with it.
Surgical patients also receive structured protein and supplementation protocols as standard care, which is precisely the intervention shown to preserve lean mass elsewhere. Some of that column difference may be the aftercare rather than the procedure. We cover the broader comparison, and its own methodological problems, in surgery versus GLP-1 drugs.
That both ratios improved is the robust finding. That one column is higher than the other is the fragile one.
The sex difference runs the other way
One stratified result deserves separating out, because it points opposite to a better-known finding. Men preserved fat-free mass better than women, especially after GLP-1 treatment.[1]
Meanwhile, women lose a larger percentage of body weight on these drugs — 10.9% against 6.8% in a review of 64 trials, covered in who loses more weight. Those are not contradictory. They are two different questions: how much total weight comes off, and what it is made of. Merging them would produce a wrong answer in either direction.
The practical implication falls on the same advice regardless: resistance training and adequate protein, which is the only intervention with randomized support for changing the mix. Our lean mass article has the figures, and protein targets has the numbers.
Frequently Asked Questions
References
- 1.Wang Z, Wang L, Zhang X, et al. Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists JAMA Network Open. 2026. PMID: 41511769.
Related research
Surgery Versus GLP-1 Drugs: Reading an Indirect Comparison
A network meta-analysis of 30 trials put surgery about 10 points ahead on total weight loss. Nobody was randomized to surgery versus a drug — and against tirzepatide alone the difference vanished.
6 min read
Bimagrumab Plus Semaglutide: The Muscle Question
The combination lost 17.8 kg at 48 weeks against 14.2 kg for semaglutide alone. But bimagrumab exists to change what you lose, and the published summary reports only how much.
6 min read
Exercise Plus a GLP-1: What Each One Actually Changes
In a four-arm randomized trial, the drug alone produced no improvement in physical fitness. Exercise alone did. Both together did most — and the strength result needs reading carefully.
6 min read
Handgrip Strength and Sarcopenic Obesity
Over twelve months on semaglutide, handgrip strength rose 4.5 kg and sarcopenic obesity fell from 49% to 33% — while lean mass declined early then stabilized rather than continuing down.
5 min read
Muscle Loss: Drug Versus Dieting
Across 20 trials in 15,782 people, the share of weight lost as lean mass was the same on incretin drugs as on dieting (p=0.42). Adding resistance training cut it from about a quarter to 17.5%.
6 min read
Muscle Volume Versus Muscle Function on a GLP-1
Psoas muscle volume fell 9.3% over 24 weeks while chair-rise time and walking speed both edged better. Mass and function moved in opposite directions in the same people — and only one of them is what anybody wants.
6 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Luvo Health
Moving between compounded and brand without changing seller
Pricing Compare
Get started →Strut Health
Semaglutide at $99/month, 48% under the register median
Pricing Compare
Get started →Care Bare Rx
Knowing which pharmacy fills the vial — it names Belmar Pharmacy
Pricing Compare
Get started →